PharmaCyte increases TNF Pharmaceuticals stake by $3 million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
September 2, 2025 9:20 AM EDTTNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartners 2025 Hype Cycle for Data Center Infrastructure Technologies
LAS VEGAS--(BUSINESS WIRE)-- PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company), today announced that it has increased its stake in TNF Pharmaceuticals (Nasdaq: TNFA, TNF) by an additional $3 million. The Company does so to help support TNFs recent acquisition of a license with LightSolver, Ltd. (LightSolver), a company recognized by Gartner and the World Economic Forum for its breakthrough innovations. The license is for its revolutionary processing... More
